Feasibility of Conducting a Clinical Trial Assessing Efficacy of Lactate as Adjunctive Therapy in Patients With Major Depressive Disorder

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Major Depressive Disorder
Interventions
DRUG

Sodium lactate

2 mmol/kg, intravenous, daily for 5 consecutive days

DRUG

Placebo

intravenous, daily for 5 consecutive days

All Listed Sponsors
collaborator

Fondation de Préfargier

UNKNOWN

lead

Centre Hospitalier Universitaire Vaudois

OTHER